Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.18 AUD -5.26% Market Closed
Market Cap: 189.3m AUD
Have any thoughts about
Arovella Therapeutics Ltd?
Write Note

Arovella Therapeutics Ltd
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arovella Therapeutics Ltd
Pre-Tax Income Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
VLS

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Arovella Therapeutics Ltd
ASX:ALA
Pre-Tax Income
-AU$8.7m
CAGR 3-Years
-20%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Pre-Tax Income
-AU$190.1m
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Pre-Tax Income
AU$167.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Pre-Tax Income
-AU$13.9m
CAGR 3-Years
-61%
CAGR 5-Years
4%
CAGR 10-Years
-38%
Probiotec Ltd
ASX:PBP
Pre-Tax Income
AU$13m
CAGR 3-Years
15%
CAGR 5-Years
19%
CAGR 10-Years
19%
Vita Life Sciences Ltd
ASX:VLS
Pre-Tax Income
AU$13m
CAGR 3-Years
14%
CAGR 5-Years
34%
CAGR 10-Years
7%

See Also

What is Arovella Therapeutics Ltd's Pre-Tax Income?
Pre-Tax Income
-8.7m AUD

Based on the financial report for Jun 30, 2024, Arovella Therapeutics Ltd's Pre-Tax Income amounts to -8.7m AUD.

What is Arovella Therapeutics Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
0%

Over the last year, the Pre-Tax Income growth was 14%. The average annual Pre-Tax Income growth rates for Arovella Therapeutics Ltd have been -20% over the past three years .

Back to Top